Analysts at Goldman Sachs think these 5 underperforming stocks could be poised to outperform, thanks to a healthy valuation discount and expected EPS growth.
The pharmaceutical giant is laying the groundwork for its next heyday.
The average yield from these stocks is more than five times the market average.
These three stocks are bargains with great dividends.
Is there still too much risk surrounding this business?
These dividend payers have a long history of steady dividend payout raises, and they both offer yields above 6% at recent prices.
When something seems too good to be true it might not be.
U.S. stocks fell yesterday as the 10-year Treasury yield rose above 4.5% amid sticky inflation. As markets turn volatile, Pfizer and Apple look like two defensive names worth considering.
Is this top healthcare stock a good buy for the long run?
We've also got a look at 3M's spinoff, gold prices, and the beef industry.